Transcription of DBL™ OCTREOTIDE INJECTION - Medsafe
{{id}} {{{paragraph}}}
Example: bankruptcy
DBL™ OCTREOTIDE INJECTION - Medsafe
Data Sheet New Zealand Version 1 DBL OCTREOTIDE INJECTION Name of medicine OCTREOTIDE acetate Presentation Each 1 mL vial of DBL OCTREOTIDE INJECTION is a clear colourless solution, containing mg, mg or mg of OCTREOTIDE acetate with the excipients, glacial acetic acid, sodium acetate trihydrate, sodium chloride and water for injections. DBL OCTREOTIDE INJECTION contains OCTREOTIDE acetate, a synthetic octapeptide analogue of Somatostatin H-D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-L-thre oninol CAS number: 79517-01-4. ( OCTREOTIDE acetate) MW: (free peptide) Uses Actions Pharmacodynamics Pharmacotherapeutic group: Antigrowth hormone (ATC code H01CB02) OCTREOTIDE is a synthetic octapeptide derivative of naturally occurring somatostatin with similar pharmacological effects, but with a considerably prolonged duration of action.
Data Sheet – New Zealand Version 4.0 1 DBL™ OCTREOTIDE INJECTION Name of medicine Octreotide acetate . Presentation . Each 1 mL vial of DBL™ Octreotide Injection is a clear colourless solution, containing 0.05 mg, 0.1 mg or
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: